Combining methods for direct cDNA selection  by Dobbie, Lorraine et al.
Technical Tips Online, Vol. 3, 1998
Combining methods for direct
cDNA selection
Lorraine Dobbiea, John C. Maulea and Anthony J. Brookesb
aMRC Human GeneticsUnit, Western General Hospital, Crewe Road, Edinburgh, UK EH4 2XU
bDepartment of Genetics and Pathology, Biomedical Center, S751 23 Upsala, Sweden
Keywords: Cloning & sequencing
▼In ‘direct cDNA selection’ protocols, cDNA fragments are
physically enriched from primary cDNA or cDNA libraries
by hybridization against immobilized genomic DNA (Ref.
1, 2, 3, 4, 5). A stringent version of direct cDNA selection,
termed end ligation coincident sequence cloning (EL-CSC)
(Ref. 6), uses a high-temperature ligation step to modify
intra-exonic restriction fragments in target cDNAs prior
to their amplification and recovery by PCR. One round
of EL-CSC can enrich target sequences by over 106 fold
but inter-exonic restriction fragments are recovered with
lower efficiency than in conventional direct cDNA selec-
tion. For maximal efficiency of transcribed sequence recov-
ery, a method would highly enrich both inter- and intra-
exonic fragments in a single cycle. Here we describe a proce-
dure, termed combination CSC (C-CSC), which combines
direct cDNA selection and EL-CSC in a single tube. We
demonstrate C-CSC by identifying human foetal brain cD-
NAs encoded in a 950 kb CEPH Mega-YAC (788H12) from
the chromosomal region 14q24.3 (Ref. 7).
The key to the C-CSC procedure is that it employs a
simply prepared cDNA restriction fragment mixture. In the
cDNA resource, some fragment ends are joined to synthetic
linkers (for selection by hybridization to genomic DNA and
enrichment by direct PCR amplification) while others are
left ‘sticky’ (to be selected by hybridization to genomic DNA
followed by genomic-DNA-directed ligation to linkers, prior
to enrichment by PCR amplification).
For demonstration purposes, C-CSC was performed as
described in the accompanying protocol. YAC 788H12 was
purified by preparative pulsed-field gel electrophoresis us-
ing a published procedure (Ref. 8). Total cDNAwas prepared
from poly(A)-selected foetal brain mRNA using published
methods (Ref. 9, 10) and Oligotex (Qiagen) according to
the manufacturer’s instructions. The reverse transcription
step was oligo-dT primed, thus providing 3‘ untranslated
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FIGURE 1. C-CSC Amplification products. Ethidium-bromide stained
1.5% agarose gel: M, HaeIII digested X DNA size marker (0-1.4 kb); C,
input cDNA; H, H product DNA; L, L product DNA.
regions which may be preferentially recovered by EL-CSC.
Since a YACwas used, additional sonicated rDNA sequences
were included with both Cot1 blocking DNAs. These com-
prised 3 µg total yeast DNA plus 2 µg of each plasmid pA
and pB (rDNA clones pA and pB were gifts fromDr Iris Gon-
zalis, Philadelphia). Finally, upon eventual elution of the
enriched cDNAs from the Dynal magnetic beads, two sepa-
rate PCR amplifications were performed. One of these PCRs
amplified the hybridization selected cDNAs (the ‘H’ prod-
ucts; equivalent to direct cDNA selection) and the other
amplified the hybridization plus ligation selected cDNAs
(the ‘L’ products; equivalent to EL-CSC). L products have
more distinctive bands and a greater average size (Fig. 1).
Both product sets were cloned into the EcoRI site of the
pBluescribe plasmid vector for further analysis.
Fluorescence sequencing (Perkin−Elmer) of inserts from
80 and 47 random H and L clones, respectively, revealed a
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Table 1. Summary of C-CSC products
Product H clones L clones Gene/ESTs in 788H12
1 4 1 L40393 YES (K)
2 3 1 L40393 YES (K)
3 1 0 L40393 YES (K)
4 0 1 L40393 YES (K)
5 6 2 L40401 YES (K)
6 3 0 L40401 YES (K)
7 4 0 L42110 (AD3) YES (K)
8 10 3 N24122 (4) YES (P)
9 1 1 T07593 ND
10 1 0 N48290 (2) YES (P)
11 1 0 R55061 (33) YES (P)
12 1 0 T79170 (2) YES (P)
13 1 0 W57637 (2) YES (P)
14 1 0 R94493 (2) YES (P)
15 0 1 R58003 ND
16 0 1 N49844 (8) ND
17 0 1 T03945 ND
18 2 1 No matches ND
19 1 3 No matches YES (S)
20 5 0 No matches YES (S)
21 2 0 No matches YES (S)
22 0 2 No matches NO (P)
23 0 3 No matches YES (S)
24 0 2 No matches ND
25 0 2 No matches Unknown (S)
Product sequences are numbered 1-25. H and L clones are
defined in the manuscript text, numbers of each are given.
Accession numbers are shown for matching dbEST and
GenBank database entries. Those beginning with L are from a
previous gene search upon YAC 788H12 (Ref. 7), with AD3
indicating the Presenilin-1 (S182) gene that causes Alzheimer
disease. Others are single examples of matching ESTs,
followed by the number of ESTs found to extend the cDNA
contig upon reiterative dbEST searches. No overlaps were
detected between the different EST groups. The YAC 788H12
localization column employs the following codes; S, Southern
blot analysis; P, PCR analysis; K, known from previous
publication (Ref. 7); ND, not determined; Unknown, failed
assay.
low number containing repeats (7 H clones and 4 L clones)
plus 1 H clone from rRNA. From the remainder, we chose
72 clones (25 sequences) for further analysis (Table 1).
These were (1) present in both the H and L products (7
sequences), and/or (2) matched to a sequence in the dbEST
transcribed sequence database (13 H and 9 L sequences,
17 total), and/or (3) present more than once in either the
H or L products (9 H and 7 L sequences, 14 total). The 8
sequences without dbEST matches have been deposited in
GenBank under accession numbers Y12016−Y12023.
It is generally believed that at most half of the total hu-
man mRNA complexity is represented in dbEST, yet over
two-thirds of our chosen C-CSC products matched ESTs.
Therefore, at least the majority of our chosen C-CSC prod-
ucts are probably genuine transcribed sequences. This is
consistent with conventional direct cDNA selection stud-
ies. To test whether these sequences were represented in
788H12, we first compared them with genes previously lo-
cated in the YAC during positional cloning of the AD3 gene
(Ref. 7). This showed seven to be known gene sequences in
YAC 788H12, including the AD3 gene itself. Second, five
products with no EST homology but with relatively long
inserts were hybridized to Southern blots of EcoRI digests
of YAC 788H12 and human genomic DNA. Of these, four
gave specific human band(s) that were present in the YAC,
and one gave no signal. Finally, primer pairs were designed
for the remaining 13 products. When tested in PCRs, six
amplified a band of expected size from human genomic
and YAC 788H12 DNAs, whilst one gave a signal only in
the human genomic DNA (the others failed to amplify clear
bands). Thus, of 19 sequences tested, 17 were confirmed to
be YAC encoded.
In conclusion, we have demonstrated that C-CSC repre-
sents a simple and effective means to combine two com-
plementary protocols for direct cDNA selection, and one in
which genuine products are easily identified.
C-CSC Protocol
C-CSC consists of six steps (Fig. 2). A number of details are
identical to those used in a publication describing EL-CSC
(Ref. 6). For brevity, these conditions are referenced in the
following procedure.
1. Two distinct double-stranded linkers (477/479:
5‘-CCGAATTCTAGAGTCGACC-3‘ plus kinased 5‘-
GATCGGTCGACTCTAGAATTCGG-3‘, and 727/731:
5‘-GCGAATTCTAGACTGCAGG-3‘ plus kinased 5‘-
GATCCCTGCAGTCTAGAATTCGC-3‘) are obtained by
annealing together the oligonucleotide components
in parallel reactions at 100 ng/µl total concentration
in 10 mM Tris/HCl, 1 mM MgCl2, pH7.0 at 37◦C for 1
h. Separately, 100 ng of each duplexed linker is ligated
to Sau3AI restriction fragments of 20 ng genomic and
100 ng primary cDNA, respectively. Digestion and
ligation conditions are as described elsewhere (Ref. 6).
2. PCR primers 478 (= 5‘ biotinylated 477) and 727
are used to amplify the genomic and cDNA mix-
tures, respectively. PCR conditions are described else-
where (Ref. 6). The amplified genomic DNA is purified
from PCR primers by electrophoresis in a 1.2% low-
melting-temperature agarose gel, followed by agarase
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FIGURE 2. The C-CSC method. Bracketed text indicates the cDNA
forms normally found in direct cDNA selection and EL-CSC and their
related reaction pathways. Details of steps 1−6 are given in the text.
Input genomic and cDNA restriction fragments are shown as solid and
open lines, respectively. Linkers/primers are shown as short solid lines
joined to DNA fragment ends; primers are drawn as inclined lines and
linkers as horizontal lines. Biotin is shown as a solid diamond. After step
3, target cDNAs are shown only if annealed to matching genomic DNA.
Angled solid lines represent capture oligonucleotides. In step 6, arrows
aligned with their respective priming sites represent PCR amplification
primers.
(Boehringer Mannheim) digestion and ethanol precipi-
tation. The amplified cDNA is ethanol precipitated, and
a Sau3AI digest used to remove linkers/primers from
some of the cDNAs. The sample is then extracted with
chloroform and ether, and ethanol precipitated. The
Sau3AI digest is performed on the total input cDNA,
however, a fraction will always fail to digest (because
it is either single stranded or the result of internal mis-
priming reactions). This digestion thus produces the
mix of linkered and unlinkered cDNA fragments re-
quired for C-CSC.
3. Two 10 µg aliquots of Cot1 human genomic DNA are
ethanol precipitated and dried. The amplified genomic
DNA fragments (1 ng per kb of sequence) and the am-
plified cDNA restriction fragments (10 µg), each in 8.4
µl H2O solutions, are used to separately resuspend the
Cot1DNAs. Next, staggered by 2.5 h, 1.8µl 1MNaOH is
added to the cDNA and then to the genomic DNA, and
each is placed at 37◦C for 5 min. After heating to 50◦C,
9.8 µl of 50◦C FNET-HClmix [6 µl formamide, 2 µl NET
(NET comprises 400 mM Tris/HCl, 2.5 M NaCl, 50 mM
EDTA, pH 7.8), 1.8 µl 1 M HCl] is added to each. They
are placed at 45◦C for 3 and 0.5 h, respectively, before
mixing together and incubating overnight at 45◦C. As
described for EL-CSC (Ref. 6), the biotinylated genomic
DNA plus hybridized cDNA fragments are then isolated
using M280 beads (DYNAL) and stringent washes (0.1x
SSC at 68◦C). This enriches the target-linkered cDNA
fragments to give the hybridization (H) products (Fig.
2, left hand panel after step 3), as well as target non-
linkered cDNA fragments (Fig. 2, right hand panel after
step 3), by removing all other cDNA sequences.
4. Two hundred and fifty nanograms ‘capture
oligonucleotide’ 732 (5‘-GGACGGGTCGACACGCG
AGGACCGAATTCTAGAGTCGACC-3‘) and 250 ng
kinased ‘capture oligonucleotide’ 735 (5‘-GATCGG-
TCGACTCTAGAATTCACCCGTGCTACCGGAACG-3‘)
are added in 1 µl and allowed to anneal with the
terminal linkers on the genomic DNA by cooling from
60◦C to room temperature over 1 h in 10 mM Tris/HCl,
1 mM EDTA, 100 mM NaCl, pH7.4.
5. A high-temperature ligation reaction is used as previ-
ously described (Ref. 6) to join the capture oligonu-
cleotides specifically to the ends of perfectly annealed
unlinkered cDNA fragments. Ligation (L) products are
thus selected from the unlinkered cDNAs.
6. Using PCR conditions described for EL-CSC (Ref. 6),
the enriched cDNA fragments are eluted in 10 µl H2O,
and the H and L products PCR amplified from 1 µl
aliquots using cDNA linker/primer 727 and EL-CSC
primers 789/596 (5‘-CGTTCCGGTAGCACGGG-3‘/5‘-
GGACGGGTCGACACGCGAGG-3‘), respectively.
References
1 Parimoo, S. et al. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 9623–9627.
2 Lovett, M., Kere, J and Hinton, L.M. (1991) Proc. Natl. Acad. Sci. U. S. A.
88, 9628–9632.
3 Abe, K. (1992) Mamm. Genome 2, 252–259.
4 Korn, B. et al. (1992) Hum. Mol. Genet. 1, 235–242.
5 Brookes, A.J. et al. (1995) Mamm. Genome 6, 257–262.
6 Brookes, A.J. et al. (1994) Hum. Mol. Genet. 3, 2011–2017.
7 Sherrington, R. et al. (1995) Nature 375, 754–760.
8 Maule, J.C., Porteous, D.J. and Brookes, A.J. (1994) Nucleic Acids Res. 22,
3245–3246.
9 Gubler, U. and Hoffman, B.J. (1983) Gene 25, 263–269.
10 Chomczynski, P. and Sacchi, N. (1987) Anal. Biochem. 162, 156–159.
Products Used
Oligotex: Oligotex from QIAGEN GmbH
agarase: agarase from Boehringer Mannheim
agar: agar from Difco
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